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In the present study we have investigated the role of human 
breast-cancer-derived fibroblasts in the proliferation of primary 
cultures of epithelial cells derived from the same tumor. For this 
purpose, a co-culture system, using Transwell tissue-culture 
inserts with microporous membranes was employed. Fibro- 
blasts and epithelial cells were enriched according to differ- 
ences in their density on Percoll density gradients. The co- 
culture system was first established using MCFJ breast cancer 
cells and a human fibroblast line (HF cells). Insulin, I7p-estradio1, 
EGF and HF cells all significantly stimulated the growth of 
MCF-7 breast cancer cells. The stimulatory effects of insulin, E2 
and EGF were additive to the stimulatory effect of HF cells. 
These data suggest that (unique) factor@), other than the 
above-mentioned growth-promoting compounds, are respon- 
sible for the growth-promoting effects of fibroblasts. In half of 
the human breast cancers investigated, tumor-derived fibro- 
blasts stimulated tumor-derived epithelial cell proliferation. 
EGF significantly stimulated epithelial cell proliferation in 4 out 
of 6 cultures. The stimulatory effects of fibroblasts and EGF 
were additive or synergistic, and were observed in the addi- 
tional presence of FCS, again suggesting production of unique 
factor(s) by the fibroblasts. In one culture the fibroblasts 
significantly inhibited epithelial tumor-cell proliferation. Con- 
versely, the epithelial cells significantly stimulated proliferation 
of fibroblasts in 3 out of 3 cultures. The somatostatin analogue 
octreotide significantly inhibited epithelial cell proliferation by 
46% in one tumor-cell culture in the absence, but not in the 
presence, of fibroblasts. In one culture, octreotide significantly 
inhibited the proliferation of fibroblasts co-cultured with epithe- 
lial cells. 
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Culturing primary human breast-cancer cells has proved to 
be difficult. The most successful method appears to be treat- 
ment of the tissue with collagenase, subsequent 1 g sedimenta- 
tion of epithelial clumps and culture of the cells in media with 
specific substitutes (Band and Sager, 1989; Smith, 1991). One 
of the reasons underlying the difficulties of culturing such cells 
may be the dependance of individual cancer cells upon an 
intact autocrine and paracrine growth-regulatory apparatus 
which is proposed to exist in vivo (Lippman et al., 1986; 
Osborne and Arteaga, 1990). Recent laboratory studies also 
point to an important role of stromal cells in the development 
and growth of breast cancer. Conditioned media from human 
breast-cancer-derived fibroblasts have been shown to enhance 
the growth of several human breast-cancer cell lines via the 
secretion of (unknown) growth factors (Enami et al., 1983; 
Adams et al., 1988; van Roozendaal et al., 1992). This stimula- 
tory effect of stromal cells on the growth of malignant breast 
epithelial cells has also been demonstrated in vivo (Horgan et 
al., 1987, 1988). 
The importance of stromal-epithelial interactions in the 
growth of epithelial tumor cells led us to investigate the growth 
of primary cultures of human breast-cancer cells in the 
absence or  presence of the corresponding tumor-derived 
fibroblasts. For this, we first separated the epithelial cells from 
the fibroblasts on discontinuous Percoll density gradients. This 
method of enrichment of breast cancer-cell populations has 
already been applied successfully (Sykes et al., 1970). Thereaf- 
ter, we co-cultured both cell populations using Transwell 
tissue-culture inserts with microporous membranes. In addi- 
tion, we also studied the effects of EGF and the somatostatin 
analogue octreotide in this co-culture system. A non- 
homogeneous distribution of receptors for somatostatin has 
been demonstrated by autoradiography (Reubi et al., 1990) in 
46% of large tumor samples of human breast-cancer tissues, 
while in the same study 25% of the somatostatin-receptor- 
positive breast tumors were shown to contain EGF-receptors. 
These 2 receptor types were not topographically overlapping in 
the majority of the cases, however. The growth factor and the 
neuropeptide may be involved in positive and negative growth 
regulation of human breast cancer cells, respectively. More 
knowledge about the interrelationship between the direct and 
indirect effects of octreotide and E G F  on the growth of human 
breast-cancer cells is of clinical importance in the light of 
recent clinical trials in which patients with advanced breast 
cancer have been treated with octreotide (Vennin et al., 1989). 
The co-culture system using Transwell tissue-culture inserts 
was first established using MCF-7 human breast cancer cells 
and human fibroblasts (HF cells). 
MATERIAL AND METHODS 
Cell dispersion and separation of cells according to 
differences in density 
Fresh tissue from 6 malignant breast tumors was obtained 
within 30 min of surgical removal. Histological diagnosis of 
tumor tissue was confirmed by routine histo-pathological 
examination. Table I shows the tumor characteristics. The 
tissue was minced into pieces of approximately 1 mm3, washed 
twice with isolation medium (see below), centrifuged at 100 g 
for 5 min, and incubated overnight in culture medium contain- 
ing 2 g/l collagenase. Thereafter, the remaining cell pellet was 
washed twice with isolation medium and incubated for another 
1 hr at 37°C with a mixture of collagenase and dispase (1 g/l 
and 2.4 x 10' U/I, respectively) to obtain a single-cell suspen- 
sion. After this incubation period the cells were washed twice 
with isolation medium. The remaining cell suspension then 
consisted of single cells. An aliquot of this suspension was 
separated and the cells were counted and plated in multi-well 
plates (see below); these represent the original cell suspen- 
sion. The remaining cells were layered on a discontinuous 
Percoll density gradient (1.04-1.05-1.06-1.07-1.08-1.10 g/ml) 
and centrifuged to isodensity for 20 min at 800 g. The cells 
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TABLE I -CHARACTERISTICS OF TUMORS STUDIED 
Patho'. ER status3 Tumor Age of SBR number patient (yr) (grade)' stage' 
- 1 36 111 TlNlh 
2 60 111 TzNo + 
3 44 I1 T, No + 
4 72 I1 T ; N ~  + 
5 68 I T2Nb + 
6 51 I TZNI. + 
~~ ~ ~ ~ 
'Scarf€, Bloom and Richardson grade.-?T,, tumor size < 2  cm; 
T2, tumor size between 2 and 5 cm; No, no positive axillary 
lymph-nodes; N,,, positive axillary lymph-nodes; Nib,, positive 
axillary top Iymph-node.-'Estrogen receptor assessed by immuno- 
histochemistry; -, negative; +, positive. 
present in the different fractions (interphases) were collected, 
washed twice with isolation medium, counted and cultured as 
described below. Percoll was obtained from Pharmacia 
(Uppsala, Sweden). 
Cell culture 
The human epithelial tumor cells with equilibrium densities 
of > 1.07 g/ml (Sykeset al., 1970), were resuspended in culture 
medium, counted and seeded in multi-well plates at a concen- 
tration of 25,000 cells per well. Fibroblasts with an equilibrium 
density of < 1.05 g/ml (Sykes et al., 1970) were resuspended in 
culture medium, counted and seeded (25,000 cells per Trans- 
well microporous membrane, 0.4 pm; Costar, Badhoevedorp, 
The Netherlands). The Transwells were transferred into wells 
containing 1 mi of culture medium with or without epithelial 
cells. Thereafter, the epithelial cells (with or without fibro- 
blasts) were incubated with or without test substances for 5-7 
days. During the last 24 hr, 3.7 x lo4 Bq of [ m e t h ~ l - ~ H ] -  
thymidine were added to the wells. The medium was removed, 
then the cells were washed twice with ice-cold 0.15 mol/l NaCI, 
suspended in 1 mol/l NaOH and transferred to vials for 
scintillation counting of the incorporated radioactivity. 
The isolation medium was Hanks' balanced salt solution 
(HBSS) supplemented with 10 g/l human serum albumin, 
penicillin (los U/l)  and sodium bicarbonate (0.4 g/l). Culture 
medium consisted of DMEM/F-12 (1:l) supplemented with 
non-essential amino acids, FCS (lo%), human transferrin (10 
pg/l; Sigma, St Louis, MO), ascorbic acid (50 pM) and sodium 
selenite (6 pg/l). Media and supplements were obtained from 
Gibco-BRL (Paisley, UK). Human transferrin and ascorbic 
acid were obtained from Sigma, and sodium selenite from 
Merck (Darmstadt, Germany). 
MCF-7 human breast cancer cells were kindly provided by 
Dr. C. Quirin-Stricker (FacultC de  Mkdecine, Strasbourg, 
France). Fibroblasts isolated from human foreskins (HF cells) 
were kindly provided by Dr. M. Ponec (Leiden, The Nether- 
lands). MCF-7 and HF cells were cultured in culture medium 
and passaged twice a week using trypsin (0.05%) and EDTA 
(0.02%). In the experimental incubations, the MCF-7 cells 
(25,000 cells seeded per well) were cultured in multi-well 
plates in 1 ml culture medium with or without HF cells (2 X los 
cells per Transwell). After 1 day of culture, the medium was 
replaced by serum-free culture medium. After another 1 day of 
incubation, this medium was replaced by medium containing 
10% growth-factor-inactivated FCS and the cells were incu- 
bated for 2 days with or without test substances. Under these 
conditions optimal stimulation of MCF-7 cell proliferation by 
mitogens such as insulin or insulin-like growth factors is 
observed (van der Burg et al., 1988). At the end of the 
incubation the DNA content of the cells was measured using 
the bisbenzimide fluorescent dye (Behring, La Jolla, CA) as 
described previously (Hofland et al., 1990). 
Insulin (bovine) was purchased from Sigma and epidermal 
growth factor from Bissendorf (Hanover, Germany). 
Imrnunocytochemical detection of keratin and BUdR 
For keratin and BUdR staining, the epithelial cells were 
cultured on glass coverslips. For keratin staining, the cells were 
fixed for 10 min with methanol at the end of the incubation 
period. Staining for keratin was done with a PAP Kit System 
(code K518; DAKO, Glostrup, Denmark). For BUdR staining, 
the cells were incubated for 60 min with 5-bromo-2'- 
deoxyuridine, washed twice with PBS, and fixed for 20 min at 
-20°C in 70% ethanol in glycin buffer (50 mmol/l, pH 2.0). 
Staining for BUdR was done with a BUdR labelling and 
detection Kit I1 from Boehringer (cat. 1299 964; Boehringer 
Mannheim, Almere, The Netherlands). The cells were double- 
stained for keratin with the PAP Kit System, as described 
above. 
Statistical analysis of data 
All values are expressed as mean s SE, n = 3 wells per 
treatment group. All data were analyzed using analysis of 
variance (ANOVA) to determine overall differences between 
treatment groups. When significant overall effects were found 
by ANOVA, a comparison between treatment groups was 
made using the Newman-Keuls test (Snedecor and Cochran, 
1980). A value of p < 0.05 was considered to be statistically 
significant. 
RESULTS 
Fibroblast-pithelial-cell interactions in cell lines 
We first established the co-culture system using Transwell 
tissue-culture inserts in MCF-7 human breast cancer cells 
co-cultured with human fibroblasts ( H F  cells). In initial 
experiments we determined the number of HF cells that were 
required to significantly stimulate MCF-7 cell proliferation. 
Figure 1 shows that a low number of HF cells (10,000-20,000 
HF cells seeded per Transwell) only slightly stimulated MCF- 
cell proliferation, while a higher number (200,000 cells) 
stimulated MCF-7 cell proliferation by 76%. In the further 
co-culture studies we therefore used this higher number of HF 
cells. In Figure 2 the effects of 17P-estradiol (E2) and insulin 
on MCF-7 cell growth with or without co-culture with H F  cells 
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F~GURE 1 - Effect of human fibroblasts (HF cells) on the growth 
of MCF-7 breast-cancer cells. HF and MCF-7 cells were co- 
cultured for 4 days using Transwell tissue-culture inserts with 
microporous membranes as described in the text. 0, MCF-7 cells 
without HF cells; a, MCF-7 cells with HF cells; *p < 0.01 and 
**p < 0.05 vs. MCF-7 cells without HF cells. 
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RGURE 2-Effect of insulin (INS) and 17P-estradiol (E2) on 
MCF-7 cell growth, with (m) or without (0) co-culture with 
human fibroblasts (HF cells). MCF-7 and HF cells were co- 
cultured for 4 days as described in the text. Insulin (10 kg/ml) and 
E2 (10 nM) were added on day 3 of culture. *p < 0.01 vs. control; 
+ p  < 0.01 1's. cells without HF cells. 
is shown. The H F  cells significantly stimulated proliferation of 
MCF-7 cells (+61%;p < 0.01 vs. cells without HF cells). E2  
(10 nM) and insulin (10 pg/ml) alone significantly stimulated 
MCF-7 cell proliferation by 76 and 75%, respectively (p < 0.01 
vs. control cells). The effects of E2 and insulin were additive 
and not synergistic to the stimulatory effect of the HF cells on 
MCF-7 cell proliferation. EGF (10 ng/ml) had, under these 
conditions, only a marginally stimulating effect (+25%, p < 
0.01 vs. control cells). Again, the effect of E G F  was additive to 
the effect of HF cells on MCF-7 cell growth (data not shown). 
Staining for keratin and incorporation of BUdR in primary 
cultures of human breast-cancer cells 
In initial experiments, we cultured cells from all fractions of 
the Percoll density gradients. On the basis of hematoxylin- 
stained preparations of these fractions, we found that cells 
with densities of less than 1.05 g/ml had a fibroblast-like 
appearance, while those with a density of more than 1.07 g/ml 
were clearly epithelial-like. The intermediate density fractions 
showed a mixture of both cell types. In the subsequent studies 
we therefore used cells with densities of < 1.05 g/ml (fibroblast 
enriched) and > 1.07 g/ml (epithelial-cell enriched) only. The 
original, unseparated, cultured-cell suspension consisted of 
both cell types, with a preponderance of fibroblasts. We also 
observed in most cultures that the Percoll-enriched fraction of 
epithelial cells grew best in the presence of fibroblasts and 
EGF (10 ngiml). Figure 3a shows an example of the staining 
for keratin of an epithelial cell population co-cultured with 
fibroblasts and EGF (10 ngiml). Virtually no fibroblasts 
(keratin-negative) are present. Figure 36 shows absence of 
staining when non-immune rabbit serum is used instead of 
rabbit antiserum to human keratin proteins. 
An example of double staining for keratin and BUdR in 
proliferating cells from the same tumor is shown in Figure 3c 
and d. Figure 3c shows that in the original, unseparated cell 
suspension both proliferating fibroblasts (blue nucleus, keratin- 
negative) and epithelial cells (blue nucleus, keratin-positive) 
are present. In contrast, Figure 3d shows that, in the enriched 
epithelial fraction, mainly proliferating epithelial cells are 
present. Therefore, measurement of 3H-thymidine incorpora- 
tion in the enriched epithelial-cell fraction will indeed repre- 
sent proliferation of epithelial cells, and we therefore per- 
formed further studies of the effects of fibroblasts on the 
proliferation of enriched epithelial breast-cancer cells. We 
also used this co-culture system to study the effects of E G F  (10 
ng/ml) and the somatostatin analogue octreotide (1 nM). 
Effect of tumor-derived fibroblasts on -'H-thymidine 
incorporation in tumor-derived epithelial cells 
Figure 4 shows the effect of Percoll-enriched fibroblasts (F) 
on 3H-thymidine incorporation of Percoll-enriched tumor- 
derived epithelial cells of 6 breast cancers. The fibroblast 
fraction significantly stimulated 3H-thymidine incorporation in 
3 out of 6 cultures (numbers 1, 2 and 5) ,  and inhibited 
?H-thymidine incorporation in one (number 3). E G F  (10 
ng/ml) alone significantly stimulated 3H-thymidine incorpora- 
tion in 4 out of 6 cultures (3, 4, 5,6). The effects of fibroblasts 
and E G F  were significantly synergistic in 2 cultures (1 and 4), 
and additive in another (5 ) .  In contrast, in the culture of tumor 
3 the fibroblast fraction significantly inhibited EGF-stimulated 
3H-thymidine incorporation. 
In 2 cultures from histologically proven non-malignant 
tissues (1 blunt duct adenosis and I chronic granulomatous 
inflammation) we found that the fibroblast fraction inhibited 
epithelial cell growth, while in one the fibroblast fraction 
completely blocked EGF-induced stimulation of epithelial cell 
proliferation (data not shown). 
The somatostatin analogue octreotide (1 nM) had no 
statistically significant effect on epithelial cell proliferation 
either in the absence or in the presence of fibroblasts in tumors 
1, 2, 4, 5 and 6, whereas in tumor 3 octreotide significantly 
inhibited epithelial-cell proliferation by 46% ( p  < 0.01 vs. 
control) only in the absence of fibroblasts (data not shown). 
In 3 cultures (tumors 2,5, and 6) we also studied 3H-thymidine 
incorporation in fibroblasts cultured in the absence and in the 
presence of epithelial cells. In addition to the stimulatory 
effect of tumor-derived fibroblasts on epithelial cell prolifera- 
tion, we found that the Percoll-enriched epithelial cells also 
significantly stimulated fibroblast proliferation. This is shown 
in Figure 5. In the presence of epithelial cells, EGF (10 ngiml) 
significantly stimulated fibroblast proliferation in all cultures 
(Table 11). In fibroblasts, co-cultured with epithelial cells, 
octreotide significantly inhibited 3H-thymidine incorporation 
in 1 out of 6 cultures (number 5). Insufficient stromal cells were 
obtained after Percoll-gradient separation to  allow us to study 
the effects of E G F  and octreotide on the growth of fibroblasts 
that were not co-cultured with tumor-derived epithelial cells. 
DISCUSSION 
Previous studies have demonstrated that human breast- 
cancer-derived stromal cells secrete factors capable of stimulat- 
ing the proliferation of breast-cancer cell lines (Enami et al., 
1983; Adams et al., 1988; van Roozendaal et al., 1992). While 
mammary tumor epithelial cell growth is regulated by steroid 
hormones and polypeptide growth factors (Lippman et al., 
1986; Osborne and Arteaga, 1990; Rosen et al., 1991), the 
nature of the stromal factors responsible for stimulation of 
epithelial cell growth is still unclear. The present study 
employed a co-culture system using Transwell microporous 
membrane inserts to investigate the role of human breast- 
cancer-derived fibroblasts in the growth regulation of epithe- 
lial cells derived from the same corresponding tumors. This 
co-culture system was first established with MCF-7 breast- 
cancer cells co-cultured with a human fibroblast line ( H F  
cells). In agreement with other studies (Adamset al., 1988; van 
der Burg et al., 1990; van Roozendaal et al., 1992) we found 
that fibroblasts are capable of stimulating the proliferation of 
MCF-7 breast-cancer cells. 
Most studies on stromal-epithelial interactions in human 
breast cancer have been performed using conditioned media 
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FIGURE 4 - Effects of breast-cancer-derived fibroblasts (F) and 10 ng/ml epidermal growth factor (EGF) on 3H-thymidine 
incorporation by Percoll-enriched epithelial cells derived from the same tumors. Fibroblasts and epithelial cells were co-cultured using 
Transwell tissue-culture inserts as described in the text. *p < 0.01 and **p < 0.05 vs. control; +p < 0.01 vs. EGF alone. CON = control, 
EGF = 10 ng/ml EGF, F = fibroblasts. 
from breast-cancer-derived stromal cells capable of stimulat- 
ing human breast-cancer cell-line proliferation (Enami et al., 
1983; Adams et al., 1988; van Roozendaal et al., 1992). In the 
present study we provide preliminary evidence of the existence 
of such an autocrine growth-stimulatory mechanism in a 
co-culture system of primary human breast-cancer cells and 
stromal cells derived from the same tumors, although the 
tumors varied considerably. In 50% of the human tumor-cell 
cultures we found that tumor-derived stromal cells stimulated 
the proliferation of epithelial cells derived from the same 
tumor. In one culture, however, the stromal cells even inhib- 
ited epithelial cell proliferation. In 2 tumor-cell cultures we 
showed that fibroblasts and E G F  acted synergistically on 
epithelial-cell proliferation, while in 3 other cultures the 
EGF-stimulatory effect was only slightly additive and not 
synergistic to the fibroblast-stimulated epithelial cell prolifera- 
tion. Finally, in one culture the tumor-derived fibroblasts even 
significantly inhibited EGF-stimulated epithelial-cell prolifera- 
tion. In 2 cultures from “non-malignant” breast-tissue-derived 
fibroblasts and epithelial cells we also observed an inhibitory 
effect of fibroblasts on epithelial-cell proliferation. These data 
are partly in agreement with the results of a recent study by van 
Roozendaal et al. (1992), who suggested a higher stimulatory 
response of breast-cancer cell lines to conditioned media of 
breast-cancer-derived fibroblasts as compared to  that of nor- 
mal breast-tissue-derived fibroblasts. They suggested that this 
was most likely determined by the phenotypic characteristics 
of the fibroblast cells involved, which may differ between 
normal tissue and tumor-derived fibroblasts. Moreover, Ad- 
ams et al. (1988) also found that normal-tissue-derived fibro- 
blast-conditioned medium had an inhibitory effect on MCF-7 
cell proliferation, while conditioned medium from tumor- 
derived fibroblasts was strongly stimulatory. Other investiga- 
tors have shown either stimulatory (Enami et al., 1983; Horgan 
et al., 1987; Miller and McInerney, 1988; van Roozendaal et al., 
1992) or inhibitory (McGrath, 1983) effects of normal-tissue- 
derived fibroblasts on epithelial cell proliferation. In the same 
co-culture system which we used in the human primary 
tumor-cell cultures, we found that normal human-foreskin 
fibroblasts were only stimulatory on human MCF-7 cell prolif- 
eration. It appears very important, therefore, to study stromal- 
epithelial interactions on cells derived from the same tissue 
specimen. 
Interestingly, we found that the tumor-epithelial cells also 
had a stimulatory effect on fibroblast proliferation. This sug- 
gests that, within human breast cancer, an autocrine growth- 
regulatory route exists in which fibroblasts stimulate epithelial 
cells and epithelial cells stimulate fibroblasts. Breast-cancer 
cells have been shown to secrete many growth factors (i.e. 
TGF-a, TGF-P and PDGF), while fibroblasts are also capable 
of secreting growth factors (Osborne and Arteaga, 1990), 
particularly IGFs (van der Burg et al., 1990). In the present 
study we did not investigate the nature of the epithelial-cell 
and fibroblast-derived factors responsible for the observed 
autocrine growth stimulation. However, our results indicate 
that fibroblasts and growth factors ( i e .  insulin, E G F  and E2) 
act additively or synergistically upon the proliferation of 
malignant breast-cancer cells. In addition, in the human 
primary-cell cultures we found that fibroblasts have a stimula- 
tory effect on breast-cancer cells, even when both cell types are 
grown in the presence of EGF and serum. This suggests that 
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FIGURE 5 - Effect of Percoll-enriched epithelial breast cancer cells on the growth of fibroblasts derived from the same tumors. Both 
cell types were co-cultured using Transwell tissue-culture inserts as described in the text. -, without epithelial cells; t, with epithelial 
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Tumor 
number ~ o n t r o ~  EGF (10 ngiml) Octreotide (1 nMl 
1 428 2 110 1450 2 153l (339) 685 f 279 
2 457 f 70 1417 2 86l(310) 349 2 23 
3 29 f 2 58 2 5’ (200) 33 f 3 
’H-thymidine incorporation (cpm per dish) 
4 77 f 11 177 2 7’ (230) 56 f 5 
5 90 2 7 1 2 6 f  6l 140 58 2 1’ (64) 
6 114 2 19 235 f 201 (206) 138 2 31 
‘p < 0.01 vs. control; values are mean f SE, control = fibro- 
blasts co-cultured with primary breast-cancer cells. Numbers in 
parentheses represent the percentage of treatment vs. control 
values. 
(unique) factors, other than the above growth-promoting 
compounds, are responsible for the growth-promoting effects 
induced by fibroblasts. The observed opposite effects of 
“non-malignant breast tissue”- and “breast-tumor tissue”- 
derived fibroblasts on epithelial cell proliferation suggest that 
the ratios of growth-stimulatory and growth-inhibitory factors 
secreted may differ between “normal” and “tumor” fibro- 
blasts, since it is unlikely that fibroblasts produce one specific 
growth factor only. 
In approximately 50% of human breast-cancer specimens, 
receptors for somatostatin have been demonstrated, while 
EGF-receptors were found in 25% of the samples containing 
somatostatin receptors. However, in only 8% of these cases 
were the 2 receptor types topographically overlapping (Reubi 
et al., 1990). On the basis of these data Reubi et af. (1990) 
suggested that, in the majority of breast tumors, it is unlikely 
that tumor biology is influenced by a direct interaction of 
somatostatin and E G F  through specific receptors in a particu- 
lar cell. In a wide variety of experimental tumor models, 
including breast cancer, growth-inhibitory effects of long- 
acting somatostatin analogues have been demonstrated in vivo 
and in vitro (Schally, 1988; Lamberts et al., 1991). The in vivo 
tumor-growth-inhibitory effects of somatostatin analogues may 
act indirectly via the inhibition of angiogenesis, immune 
modulatory effects and inhibition of the secretion of “endo- 
crine” growth factors such as growth hormone, prolactin and 
IGF-I, as well as via direct effects on tumor cells via specific 
somatostatin receptors. These last-named effects include inhi- 
bition of EGF-receptor activity via the stimulation of a tyrosine 
phosphatase or inhibition of the secretion of autocrine and 
paracrine growth factors (Lamberts et al., 1991). Because our 
study showed clear evidence of the existence of a paracrine 
growth-regulatory mechanism, we also studied the effect of the 
somatostatin analogue octreotide on epithelial-cell and fibro- 
blast proliferation with or without co-culture. We found that 
octreotide had no effect on basal and fibroblast-stimulated 
epithelial cell proliferation in 5 of 6 tumors, while in one tumor 
octreotide inhibited epithelial-cell proliferation in the absence 
of fibroblasts only. Surprisingly, we found in one culture that 
octreotide significantly inhibited the proliferation of fibro- 
blasts co-cultured with epithelial cells. Although we did not 
investigate the somatostatin-receptor status of the tumors, it 
can be speculated that octreotide inhibits the secretion of 
growth factors by the epithelial tumor cells, thereby indirectly 
inhibiting growth of the co-cultured fibroblasts. In the 7-day 
co-culture period used in our study, this growth-inhibitory 
effect of octreotide upon fibroblast proliferation did not result 
in an indirect growth inhibition of epithelial cells. Therefore, 
more studies are clearly needed to  evaluate the potential role 
of the somatostatin analogue octreotide in the treatment of 
breast cancer. 
In conclusion, our study emphasizes the need to investigate 
the role of stromal cells in breast-cancer epithelial-cell prolif- 
eration, as well as their role in interfering with drug-induced 
manipulation of breast-cancer cell growth. 
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